Published in Methods Enzymol on January 01, 1978
Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites. Anal Chem (2007) 1.43
Purification and characterization of a soybean flour-induced cytochrome P-450 from Streptomyces griseus. J Bacteriol (1989) 1.02
An efficient light-driven P450 BM3 biocatalyst. J Am Chem Soc (2013) 0.96
Electrochemiluminescent/voltammetric toxicity screening sensor using enzyme-generated DNA damage. Biosens Bioelectron (2007) 0.90
Defining resonance Raman spectral responses to substrate binding by cytochrome P450 from Pseudomonas putida. Biopolymers (2008) 0.90
Control of electrochemical and ferryloxy formation kinetics of cyt P450s in polyion films by heme iron spin state and secondary structure. J Am Chem Soc (2009) 0.89
Resonance Raman spectroscopy reveals that substrate structure selectively impacts the heme-bound diatomic ligands of CYP17. Biochemistry (2013) 0.84
Using resonance Raman cross-section data to estimate the spin state populations of Cytochromes P450. J Raman Spectrosc (2013) 0.83
Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis. Protein Sci (1996) 0.82
Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7. J Biol Inorg Chem (2009) 0.79
The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity. J Biol Inorg Chem (2008) 0.78
13C-Methyl isocyanide as an NMR probe for cytochrome P450 active sites. J Biomol NMR (2009) 0.76
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer (1981) 3.90
Unique biochemical events in bacterial sporulation. Annu Rev Microbiol (1970) 3.11
Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science (1993) 3.00
Enzymatic omega-oxidation. I. Electon carriers in fatty acid and hydrocarbon hydroxylation. J Biol Chem (1966) 2.83
Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure (1995) 2.64
Enzymatic omega-oxidation. II. Function of rubredoxin as the electron carrier in omega-hydroxylation. J Biol Chem (1967) 2.62
An exploration of the activity theory of aging: activity types and life satisfaction among in-movers to a retirement community. J Gerontol (1972) 2.49
Convergent and alternative designs in the digital adhesive pads of scincid lizards. Science (1982) 2.34
Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A (1999) 2.30
Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci U S A (1977) 2.16
Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet (1998) 2.07
Expression of differentiated functions in hepatoma cell hybrids: induction of mouse albumin production in rat hepatoma-mouse fibroblast hybrids. Proc Natl Acad Sci U S A (1972) 1.90
Pivotal role of water in the mechanism of P450BM-3. Biochemistry (2001) 1.81
Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr (1976) 1.77
Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol (1994) 1.70
Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis (1976) 1.66
Medicaid in the inner city: the case of maternity care in Chicago. Milbank Q (1990) 1.62
Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest (1992) 1.60
Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol (1992) 1.59
How similar are P450s and what can their differences teach us? Arch Biochem Biophys (1999) 1.57
Physician supply and Medicaid participation. The causes of market failure. Med Care (1989) 1.56
Enzymatic omega-oxidation. 3. Purification and properties of rubredoxin, a component of the omega-hydroxylation system of Pseudomonas oleovorans. J Biol Chem (1968) 1.56
A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res (1991) 1.50
The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J Biol Chem (1996) 1.48
Medicaid and access to child health care in Chicago. J Health Polit Policy Law (1992) 1.45
Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell Biol (1997) 1.43
Ligand binding to heme proteins. An evaluation of distal effects. J Biol Chem (1983) 1.42
Investigations of cyanide as an infrared probe of hemeprotein ligand binding sites. J Biol Chem (1985) 1.36
A three-dimensional model of aromatase cytochrome P450. Protein Sci (1995) 1.30
Myoglobin in a cyanobacterium. Science (1992) 1.28
Stimulation of rat liver mitochondrial adenosine triphosphatase by anions. J Biol Chem (1975) 1.24
Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. J Biol Chem (1976) 1.20
Oxygenated cytochrome P-450 and its possible role in enzymic hydroxylation. Biochem Biophys Res Commun (1971) 1.17
An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. J Biol Chem (1997) 1.17
Cytochrome content of two pseudomonads containing mixed-function oxidase systems. J Bacteriol (1970) 1.15
An N-methyl glutamate dehydrogenase from Pseudomonas M.A. Arch Biochem Biophys (1971) 1.14
Medicaid patients' access to office-based obstetricians. J Health Care Poor Underserved (1991) 1.14
Changes in cytochrome content and electron transport patterns in Pseudomonas putida as a function of growth phase. J Bacteriol (1978) 1.13
Heme A of cytochrome c oxicase. Structure and properties: comparisons with hemes B, C, and S and derivatives. J Biol Chem (1975) 1.12
Fatty acid monooxygenation by cytochrome P-450BM-3. J Biol Chem (1990) 1.12
Structural alignments of P450s and extrapolations to the unknown. Methods Enzymol (1996) 1.10
Ring 1 chromosome and dwarfism--a possible syndrome. J Pediatr (1967) 1.09
Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction. Biochemistry (1972) 1.06
Nitration and inactivation of cytochrome P450BM-3 by peroxynitrite. Stopped-flow measurements prove ferryl intermediates. Eur J Biochem (2000) 1.03
Magnetic and spectroscopic probes for FeOFe linkages in hemin systems. Bioinorg Chem (1975) 1.01
Single turnover kinetics of the reaction between oxycytochrome P-450cam and reduced putidaredoxin. J Biol Chem (1988) 1.01
EPR-spectroscopy of reduced oxyferrous-P450cam. FEBS Lett (1991) 1.01
Studies of the oxygen binding site of cytochrome P-450. Nitric oxide as a spin-label probe. J Biol Chem (1978) 1.00
Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell Biol (1996) 0.99
P450s: structural similarities and functional differences. FASEB J (1996) 0.99
Kinetic studies on rat liver and beef heart mitochondrial ATPase. Evidence for nucleotide binding at separate regulatory and catalytic sites. J Biol Chem (1975) 0.98
Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet (1983) 0.98
The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains. Biochemistry (1996) 0.96
Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol Endocrinol (1993) 0.94
NADPH-P-450 reductase: structural and functional comparisons of the eukaryotic and prokaryotic isoforms. Biochimie (1995) 0.94
Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3. Biochemistry (1996) 0.94
Association of cytochromes P450 with their reductases: opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system. Biochemistry (2000) 0.94
Effects of bereavement on indicators of mental health in elderly widows and widowers. J Gerontol (1983) 0.93
Expression, purification, and properties of the flavoprotein domain of cytochrome P-450BM-3. Evidence for the importance of the amino-terminal region for FMN binding. J Biol Chem (1991) 0.92
Discontinuous variability, in the form of a geometric progression, of albumin production in hepatoma and hybrid cells. Proc Natl Acad Sci U S A (1974) 0.92
Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch Biochem Biophys (1992) 0.91
Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras. J Biol Chem (1994) 0.91
NADPH-cytochrome c (P-450) reductase. Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates. J Biol Chem (1979) 0.90
Rapid reactions of peroxynitrite with heme-thiolate proteins as the basis for protection of prostacyclin synthase from inactivation by nitration. Arch Biochem Biophys (2000) 0.90
Nitric oxide complexes of cytochrome P-450. FEBS Lett (1975) 0.90
Failure of naturally acquired rhinovirus infections to produce temporal immunity to heterologous serotypes. Infect Immun (1974) 0.90
The exchange of phospholipids between cultured chick embryo fibroblasts and their growth medium. Exp Cell Res (1969) 0.90
Dynamics of protein-bound water in the heme domain of P450BM3 studied by high-pressure spectroscopy: comparison with P450cam and P450 2B4. Biochemistry (1999) 0.90
Protective function of human milk: the milk fat globule. Semin Perinatol (1999) 0.89
Spectroscopical and functional characterization of the hemoglobin of Nostoc commune (UTEX 584 (Cyanobacterial). Biochim Biophys Acta (1996) 0.89
Equilibrium and kinetic studies of the interaction of cytochrome P-450cam and putidaredoxin. J Biol Chem (1982) 0.89
Cell hybridization. Methods Enzymol (1974) 0.89
Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide. Am J Clin Oncol (2000) 0.89
Intraocular pressure and outflow facility are unchanged following acute and chronic intracameral chondroitinase ABC and hyaluronidase in monkeys. Exp Eye Res (1997) 0.88
Bacterial cytochromes P450: isolation and identification. Methods Enzymol (1991) 0.87
Pre-steady-state kinetics of the activation of rabbit skeletal muscle myosin light chain kinase by Ca2+/calmodulin. J Biol Chem (1992) 0.87
Possible higher valence states of cytochrome P-450 during oxidative reactions. Biochem Biophys Res Commun (1974) 0.87
Reconstitution of the fatty acid hydroxylation function of cytochrome P-450BM-3 utilizing its individual recombinant hemo- and flavoprotein domains. J Biol Chem (1992) 0.87
Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily. Proc Natl Acad Sci U S A (1992) 0.87
Acute effects of H-7 on ciliary epithelium and corneal endothelium in monkey eyes. Curr Eye Res (2001) 0.87
Pseudomonas putida cytochrome P-450: characterization of an oxygenated form of the hemoprotein. Arch Biochem Biophys (1972) 0.86
H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys. Invest Ophthalmol Vis Sci (1999) 0.86
Acute epidural abscess. Am J Emerg Med (1987) 0.86
Thr268 in substrate binding and catalysis in P450BM-3. Arch Biochem Biophys (1998) 0.86
Single turnover studies with oxy-cytochrome P-450cam. Arch Biochem Biophys (1986) 0.85
Modulation of leucine transaminase activity by dietary means. Am J Physiol (1975) 0.85
Analysis of discontinuous variation in albumin production by hepatoma cells at the cellular level. Somatic Cell Genet (1979) 0.85
The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations. Drug Metab Dispos (1974) 0.85
Hospital outpatient services and Medicaid patients' access to care. Med Care (1991) 0.85
Influence of aurovertin on mitochondrial ATPase activity. J Biol Chem (1975) 0.85
Purification and properties of putidaredoxin reductase. J Biol Chem (1983) 0.84
Analysis of variability in albumin content of sister hepatoma cells and a model for geometric phenotypic variability (quantitative shift model). Somat Cell Mol Genet (1984) 0.84
The reduction of putidaredoxin reductase by reduced pyridine nucleotides. Arch Biochem Biophys (1988) 0.84
Anti-BA46 monoclonal antibody Mc3: humanization using a novel positional consensus and in vivo and in vitro characterization. Cancer Res (1995) 0.84